Foresee Pharmaceuticals Overview
- Year Founded
-
2013
- Status
-
Public
- Employees
-
34
- Stock Symbol
-
6576
- Share Price
-
$2.19
- (As of Friday Closing)
Foresee Pharmaceuticals General Information
Description
Foresee Pharmaceuticals Co Ltd main activity is applying stabilized injectable formulation (SIF) platform technology to produce products for anticancer and treatment of chronic diseases. Its pipeline includes CAMCEVI (Leuprolide, FP-001), FP-014 (Triptorelin), Aderamastat (FP-025, MMP-12 Inhibitor), Linvemastat (FP-020, MMP-12 Inhibitor), and others. The Group operates business only in a single industry of new drug development, and all of its revenue is generated from Taiwan.
Contact Information
Website
www.foreseepharma.comCorporate Office
- 9F-2., No.19-3, Sanchong Road
- Nangang District
- Taipei, 115
- Taiwan
Corporate Office
- 9F-2., No.19-3, Sanchong Road
- Nangang District
- Taipei, 115
- Taiwan
Foresee Pharmaceuticals Stock Performance
As of 13-Nov-2026, Foresee Pharmaceuticals’s stock price is $2.19. Its current market cap is $345M with 158M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $2.19 | $2.19 | $2.03 - $3.06 | $345M | 158M | 119K |
Foresee Pharmaceuticals Financials Summary
As of 30-Jun-2026, Foresee Pharmaceuticals has a trailing 12-month revenue of $15.2M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 383,640 | 385,450 | 350,323 | 377,882 |
| Revenue | 15,166 | 13,825 | 13,047 | 6,262 |
| EBITDA | 4,432 | (25,730) | (30,360) | (30,040) |
| Net Income | 724 | (28,310) | (33,688) | (33,270) |
| Total Assets | 58,265 | 41,901 | 65,660 | 60,578 |
| Total Debt | 12,489 | 7,410 | 7,916 | 7,428 |
Foresee Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Foresee Pharmaceuticals Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Foresee Pharmaceuticals Patents
Foresee Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20250302739-A1 | Long-acting injectable pharmaceutical compositions comprising biodegradable polymers for drug delivery | Pending | 13-Jun-2025 | ||
| WO-2025264950-A1 | Crystalline dihydrotetrabenazine and the method thereof | Pending | 21-Jun-2024 | ||
| AU-2024214835-A1 | Long-acting injectable (lai) composition of cariprazine | Pending | 03-Feb-2023 | ||
| EP-4658273-A2 | Long-acting injectable (lai) composition of cariprazine | Pending | 03-Feb-2023 | ||
| WO-2024163824-A2 | Long-acting injectable (lai) composition of cariprazine | Inactive | 03-Feb-2023 | A61K9/0019 |
Foresee Pharmaceuticals Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Foresee Pharmaceuticals Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Foresee Pharmaceuticals ESG
Risk Overview
Risk Rating
Updated May, 31, 2023
36.28 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 14,766
Rank
Percentile
Pharmaceuticals
Industry
of 891
Rank
Percentile
Pharmaceuticals
Subindustry
of 435
Rank
Percentile
Foresee Pharmaceuticals FAQs
-
When was Foresee Pharmaceuticals founded?
Foresee Pharmaceuticals was founded in 2013.
-
Where is Foresee Pharmaceuticals headquartered?
Foresee Pharmaceuticals is headquartered in Taipei, Taiwan.
-
What is the size of Foresee Pharmaceuticals?
Foresee Pharmaceuticals has 34 total employees.
-
What industry is Foresee Pharmaceuticals in?
Foresee Pharmaceuticals’s primary industry is Drug Discovery.
-
Is Foresee Pharmaceuticals a private or public company?
Foresee Pharmaceuticals is a Public company.
-
What is Foresee Pharmaceuticals’s stock symbol?
The ticker symbol for Foresee Pharmaceuticals is 6576.
-
What is the current stock price of Foresee Pharmaceuticals?
As of 13-Nov-2026 the stock price of Foresee Pharmaceuticals is $2.19.
-
What is the current market cap of Foresee Pharmaceuticals?
The current market capitalization of Foresee Pharmaceuticals is $345M.
-
What is Foresee Pharmaceuticals’s current revenue?
The trailing twelve month revenue for Foresee Pharmaceuticals is $15.2M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
